Revolution Medicines, Inc. (RVMD) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 4.8% on average (either way), rising 5 times and falling 7. EPS beat estimates 2 of 12 times; revenue 2 of 2. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-11-04 | -1.90 | -2.35 | +19.1% | 197.6M | 25.6M | -8.5% |
| Q3 FY2026 | 2026-08-05 | -3.06 | -2.04 | -50.0% | n/a | 1.8M | +2.2% |
| Q2 FY2026 | 2026-05-06 | -2.29 | -1.84 | -24.5% | n/a | 2.4M | -3.2% |
| Q1 FY2026 | 2026-02-25 | -1.86 | -1.58 | -17.7% | n/a | 3.7M | -2.6% |
| Q4 FY2025 | 2025-11-05 | -1.61 | -1.42 | -13.4% | n/a | 1.7M | +4.8% |
| Q3 FY2025 | 2025-08-06 | -1.31 | -1.14 | -15.1% | n/a | 27.5M | -9.0% |
| Q2 FY2025 | 2025-05-07 | -1.13 | -1.12 | -0.9% | n/a | 1.2M | +11.9% |
| Q1 FY2025 | 2025-02-26 | -1.12 | -1.01 | -10.9% | n/a | 375000 | -5.5% |